The University of Chicago Header Logo

Search Results (706)

MatchTypeWhy
Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.Academic Article Why?
Multidisciplinary care of the patient with head and neck cancer.Academic Article Why?
Mutated HRAS Activates YAP1-AXL Signaling to Drive Metastasis of Head and Neck Cancer.Academic Article Why?
Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression.Academic Article Why?
Surgical complications in patients with head and neck cancer receiving chemotherapy.Academic Article Why?
Activation of the NOTCH pathway in head and neck cancer.Academic Article Why?
Allelic loss at the GPx-1 locus in cancer of the head and neck.Academic Article Why?
Aspiration in chemoradiated patients with head and neck cancer.Academic Article Why?
Benefits of chemotherapy in head and neck cancer.Academic Article Why?
Carotid sinus syncope in head and neck cancer.Academic Article Why?
Combined modality therapy of head and neck cancer.Academic Article Why?
Concurrent chemoradiotherapy for head and neck cancer.Academic Article Why?
Curative treatment for advanced head and neck cancer in the community: has the time come?Academic Article Why?
Etodolac improves 5-FU sensitivity of head and neck cancer cells through inhibition of thymidylate synthase.Academic Article Why?
Functional outcomes in head and neck cancer.Academic Article Why?
Per Page    Page  of 48last Nextnext
Prev
Search Criteria
  • Head and Neck Cancer
Filter by Type
_
Click "Why?" to see why an item matched the search.